Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of premature menopause after treatment for Hodgkin's lymphoma.
Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, Hancock BW, Harris SJ, Horwich A, Hoskin PJ, Linch DC, Lister A, Lucraft HH, Radford J, Stevens AM, Syndikus I, Williams MV; England and Wales Hodgkin Lymphoma Follow-up Group. Swerdlow AJ, et al. Among authors: cunningham d. J Natl Cancer Inst. 2014 Aug 19;106(9):dju207. doi: 10.1093/jnci/dju207. Print 2014 Sep. J Natl Cancer Inst. 2014. PMID: 25139687
Repeat administration of high dose melphalan in relapsed myeloma.
Mansi JL, Cunningham D, Viner C, Ellis E, Meldrum M, Milan S, Gore M. Mansi JL, et al. Among authors: cunningham d. Br J Cancer. 1993 Nov;68(5):983-7. doi: 10.1038/bjc.1993.466. Br J Cancer. 1993. PMID: 8217614 Free PMC article.
EPIC: an effective low toxicity regimen for relapsing lymphoma.
Hickish T, Roldan A, Cunningham D, Mansi J, Ashley S, Nicolson V, Gore ME, Catovsky D, Smith IE. Hickish T, et al. Among authors: cunningham d. Br J Cancer. 1993 Sep;68(3):599-604. doi: 10.1038/bjc.1993.393. Br J Cancer. 1993. PMID: 8353050 Free PMC article. Clinical Trial.
Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
Bamias A, Hill ME, Cunningham D, Norman AR, Ahmed FY, Webb A, Watson M, Hill AS, Nicolson MC, O'Brien ME, Evans TC, Nicolson V. Bamias A, et al. Among authors: cunningham d. Cancer. 1996 May 15;77(10):1978-85. doi: 10.1002/(SICI)1097-0142(19960515)77:10<1978::AID-CNCR3>3.0.CO;2-D. Cancer. 1996. PMID: 8640659 Clinical Trial.
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report.
Linch DC, Vaughan Hudson B, Hancock BW, Hoskin PJ, Cunningham DC, Newland AC, Milligan DW, Stevenson PA, Wood JK, MacLennan KA, Anderson L, Gregory WM, Vaughan Hudson G. Linch DC, et al. Among authors: cunningham dc. Br J Cancer. 1996 Jul;74(2):318-22. doi: 10.1038/bjc.1996.360. Br J Cancer. 1996. PMID: 8688344 Free PMC article. Clinical Trial.
2,206 results